The record, in your language.

Why it matters — In the fieldRecA-coated gold nanoconjugates that image DNA double-strand-break repair in living cells in real time — resolving repair dynamics without GFP/RFP genetic tagging.

Why it matters — For another fieldTurns a gold nanoparticle into a live camera for DNA damage — letting scientists watch cells repair broken DNA as it happens.

Why it matters — Clinical & healthA label-free readout of DNA-repair dynamics that could sharpen study of the genome instability behind cancer and antimicrobial resistance.

Why it matters — Industry & innovationA tag-free, nanoparticle-based DNA-damage imaging platform — a licensable basis for research tools, drug screens and diagnostics.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldComparative urinary metabolomics maps the shared and disease-specific metabolic pathways separating COVID-19 from liver disease — non-invasive biomarker leads.

Why it matters — For another fieldReads a simple urine sample to find chemical fingerprints that tell COVID-19 and liver disease apart.

Why it matters — Clinical & healthPoints to non-invasive urinary biomarkers that could aid differential diagnosis and monitoring across COVID-19 and hepatic disease.

Why it matters — Industry & innovationCandidate urinary-metabolite panels — a starting point for non-invasive diagnostic assays.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldFecal microbiota transplantation reduces neuropathic pain in rats through gut-microbiota-driven immunomodulation of ion channels and nociceptors — a gut–nerve axis mechanism.

Why it matters — For another fieldShows that changing gut bacteria can dial down nerve pain — the microbiome talking to the nervous system.

Why it matters — Clinical & healthEarly mechanistic support for microbiome-directed approaches to chronic neuropathic pain.

Why it matters — Industry & innovationA microbiome-based therapeutic direction for pain — rationale for live-biotherapeutic development.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldDeleting SeqA drives low-level fluoroquinolone resistance in E. coli via transcriptional reprogramming and an RpoS-dependent stress response — a chromosome-maintenance route to antibiotic tolerance.

Why it matters — For another fieldRemoving one DNA-organising protein makes bacteria harder to kill with common antibiotics — a fresh angle on how resistance emerges.

Why it matters — Clinical & healthIdentifies a genetic-regulatory pathway to fluoroquinolone resistance relevant to how low-level tolerance seeds treatment failure.

Why it matters — Industry & innovationHighlights SeqA/RpoS regulation as a target space for anti-resistance strategies.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldA cross-ethnic gut-microbiome comparison finds enrichment of oral pathobionts in a North Indian IBD cohort — population-specific microbial signatures of inflammatory bowel disease.

Why it matters — For another fieldFinds that mouth-dwelling bacteria colonise the gut more in Indian IBD patients — geography shapes the disease's microbial signature.

Why it matters — Clinical & healthSuggests population-specific microbial markers for IBD, informing diagnosis and stratification beyond Western cohorts.

Why it matters — Industry & innovationPopulation-aware microbiome signatures — inputs for diagnostics and stratified therapeutics in IBD.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldA bacteria-to-human map of the protein networks that generate spontaneous DNA damage — a systems-level account of where endogenous mutation originates.

Why it matters — For another fieldShows the same protein systems that damage DNA in bacteria also operate in human cells — a shared, cross-species origin for mutation.

Why it matters — Clinical & healthThe endogenous DNA-damage pathways mapped here underlie mutation processes relevant to cancer initiation and to how infections acquire resistance.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldHigh-dose gold nanoparticles remodel ribosomal-protein expression and accelerate bacterial growth — a mechanism that constrains safe nanoconjugate design.

Why it matters — For another fieldShows nanomaterials aren't inert inside living cells: gold particles change how bacteria build proteins and grow.

Why it matters — Clinical & healthDefines a safety boundary for gold-nanoparticle agents intended for use in diagnostics and therapy.

Why it matters — Industry & innovationSets a safe-design limit for gold-nanoparticle products — essential for anyone commercialising nanoconjugate diagnostics or therapeutics.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldAn extraction-free, saliva-based Cas13a workflow for SARS-CoV-2 — a simplified rapid molecular diagnostic.

Why it matters — For another fieldUses CRISPR not to edit genes but to detect a virus, directly from saliva.

Why it matters — Clinical & healthA point-of-care-friendly test that skips complex RNA extraction — faster testing pathways for clinics and field settings.

Why it matters — Industry & innovationA licensable, low-cost rapid-diagnostic workflow — a template for scalable, extraction-free molecular test kits.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldFirst-author work revealing an abrupt, global transition in E. coli sister-chromosome separation, with late-splitting intersister snaps.

Why it matters — For another fieldReveals the physical choreography by which a bacterium pulls its two DNA copies apart just before dividing.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldFirst-author demonstration that the fork-tracking protein SeqA regulates sister-chromosome cohesion.

Why it matters — For another fieldIdentifies a molecular 'clasp' that keeps freshly-copied bacterial DNA paired — a control point in cell division.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldEngineered fluorescent reporters that flag spontaneous DNA double-strand breaks in living human and bacterial cells.

Why it matters — For another fieldTurns proteins into living 'sensors' that glow wherever DNA breaks — a way to watch damage as it happens.

Why it matters — Clinical & healthA live-cell DNA-break sensor relevant to studying genome instability in disease, including cancer.

Why it matters — Industry & innovationThe sensing principle behind the lab's label-free DNA-damage-detection platform — a basis for diagnostic tooling.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldCharacterised enrichment of lactic-acid-producing bacteria in the fecal microbiota of North-Indian ulcerative-colitis patients.

Why it matters — For another fieldMaps how gut-bacterial communities shift in an inflammatory bowel disease.

Why it matters — Clinical & healthMicrobiome signatures in ulcerative colitis that could inform patient stratification and microbiome-directed care.

Why it matters — Industry & innovationPoints to microbiome biomarkers of potential interest to diagnostics and probiotic development.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldReal-world intention-to-treat analysis of fecal-microbiota-therapy efficacy in steroid-dependent ulcerative colitis.

Why it matters — For another fieldTests whether transplanting healthy gut bacteria helps a hard-to-treat bowel disease.

Why it matters — Clinical & healthReal-world evidence on fecal microbiota therapy for steroid-dependent ulcerative colitis — directly relevant to gastroenterology practice.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldSynthesis and characterisation of novel transition-metal Schiff-base complexes with antimicrobial activity.

Why it matters — For another fieldNew designed metal compounds that can kill microbes — chemistry meeting antimicrobial biology.

Why it matters — Clinical & healthEarly-stage antimicrobial candidates of potential interest against resistant infections.

Why it matters — Industry & innovationNovel antimicrobial chemotypes — early, IP-relevant leads for antimicrobial development.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldShowed that a distant chromosome-membrane attachment blocks DNA-replication initiation in E. coli.

Why it matters — For another fieldFinds that tethering DNA to the cell membrane can pause its copying — a timing mechanism for growth.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldReview synthesising the immunopathological determinants of COVID-19 outcomes.

Why it matters — For another fieldPulls together why some COVID-19 cases resolve and others turn severe, from an immune-system view.

Why it matters — Clinical & healthA clinically-oriented synthesis of the immune determinants of COVID-19 recovery versus death.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.

Why it matters — In the fieldMethods chapter: multilocus FISH imaging of the E. coli chromosome.

Why it matters — For another fieldA how-to for imaging bacterial DNA at many points at once.

Showing this paper's most general view — it doesn't carry a distinct take for that audience.